Literature DB >> 20338969

The role of peritoneal lavage and the prognostic significance of mesothelial cell area in preventing encapsulating peritoneal sclerosis.

Tadashi Yamamoto1, Kyoko Nagasue, Senji Okuno, Tomoyuki Yamakawa.   

Abstract

BACKGROUND: Severe peritoneal injury and encapsulating peritoneal sclerosis (EPS) as complications of long-term peritoneal dialysis (PD) are issues of concern. The usefulness of peritoneal lavage after withdrawal of PD and the risk factors for EPS have not been addressed until now. Little is known about mesothelial cell area (MCA) in the effluent as a marker of peritoneal injury. In the present study, we investigated the clinical significance of peritoneal lavage after PD withdrawal and tried to clarify the risk factors related to MCA, with the aim of preventing EPS. We also developed an algorithm for the clinical management of long-term PD patients.
METHODS: We assigned 247 PD patients to one of two cohorts after PD withdrawal: a non-lavage group (73 patients) and a lavage group (174 patients). To clarify the risk factors, we studied these potential predictors: PD duration, dialysate-to-plasma ratio of creatinine (D/P Cr) at the time of PD withdrawal, frequency of peritoneal lavage, type of PD or lavage solution, MCA at the time of PD withdrawal ("PD area"), and MCA at the time of peritoneal lavage withdrawal or censoring ("LA area"). Recurrent intestinal obstruction was defined as the main manifestation of EPS. Diagnostic performance and cut-off values were then calculated for the selected risk factors.
RESULTS: The overall incidence of EPS was significantly lower in the lavage group, at 6.9% (5.2% during lavage and 2.5% after lavage), than in the non-lavage group, at 15.1%. The risk factors and cut-off values were PD area (350 µm(2)) and PD duration (78 months) for the non-lavage group; and PD area (350 µm(2)) and LA area (320 µm(2)) for the lavage group. Patients with a PD duration of 78 months or more and a PD area of 350 µm(2) or more were defined as high-risk patients in the non-lavage group (risk ratio: 11.14), and patients with a PD area of 350 µm(2) or more and an LA area of 320 µm(2) or more were defined as high-risk patients in the lavage group (risk ratio: 10.43).
CONCLUSIONS: Peritoneal lavage is effective in reducing the incidence of EPS after PD withdrawal. The PD duration and MCA are significant risk factors, and these markers are useful for classifying patients into low- and high-risk groups for the development of EPS.

Entities:  

Mesh:

Year:  2010        PMID: 20338969     DOI: 10.3747/pdi.2008.00273

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  13 in total

1.  Morphological characteristics in peritoneum in patients with neutral peritoneal dialysis solution.

Authors:  Chieko Hamada; Kazuho Honda; Kunio Kawanishi; Hirotaka Nakamoto; Yasuhiko Ito; Tsutomu Sakurada; Yudo Tanno; Toru Mizumasa; Masanobu Miyazaki; Misaki Moriishi; Masaaki Nakayama
Journal:  J Artif Organs       Date:  2015-02-14       Impact factor: 1.731

2.  A case of encapsulating peritoneal sclerosis presented shortly after renal transplantation.

Authors:  Georgios Spanos; Haralampos V Harissis; Evangelia Dounousi; Michalis Mitsis; Haralampos Pappas; Georgios K Georgiou; Kostas C Siamopoulos; Michalis Fatouros
Journal:  CEN Case Rep       Date:  2013-06-14

Review 3.  Encapsulating peritoneal sclerosis: the state of affairs.

Authors:  Mario R Korte; Denise E Sampimon; Michiel G H Betjes; Raymond T Krediet
Journal:  Nat Rev Nephrol       Date:  2011-08-02       Impact factor: 28.314

4.  American Society of Nephrology quiz and questionnaire 2012: renal replacement therapy.

Authors:  Rajnish Mehrotra; Richard J Glassock; Anthony J Bleyer
Journal:  Clin J Am Soc Nephrol       Date:  2013-04-04       Impact factor: 8.237

5.  Risk factors for drainage-requiring ascites after refractory peritonitis in peritoneal dialysis patients.

Authors:  Cheng-Chia Lee; Kun-Hua Tu; Hsiao-Hui Chen; Ming-Yang Chang; Cheng-Chieh Hung
Journal:  Int Urol Nephrol       Date:  2016-08-05       Impact factor: 2.370

6.  Vascular endothelial growth factor receptor-3 is a novel target to improve net ultrafiltration in methylglyoxal-induced peritoneal injury.

Authors:  Takeshi Terabayashi; Yasuhiko Ito; Masashi Mizuno; Yasuhiro Suzuki; Hiroshi Kinashi; Fumiko Sakata; Takako Tomita; Daiki Iguchi; Mitsuhiro Tawada; Ryosuke Nishio; Shoichi Maruyama; Enyu Imai; Seiichi Matsuo; Yoshifumi Takei
Journal:  Lab Invest       Date:  2015-06-29       Impact factor: 5.662

7.  Encapsulating peritoneal sclerosis in an Italian center: thirty year experience.

Authors:  Valerio Vizzardi; Massimo Sandrini; Silvia Zecchini; Sara Ravera; Luigi Manili; Giovanni Cancarini
Journal:  J Nephrol       Date:  2015-10-31       Impact factor: 3.902

Review 8.  Encapsulating peritoneal sclerosis-a rare but devastating peritoneal disease.

Authors:  Zia Moinuddin; Angela Summers; David Van Dellen; Titus Augustine; Sarah E Herrick
Journal:  Front Physiol       Date:  2015-01-05       Impact factor: 4.566

9.  Elastase, α1-proteinase inhibitor, and interleukin-8 in children and young adults with end-stage kidney disease undergoing continuous ambulatory peritoneal dialysis.

Authors:  Bożena Polańska; Daria Augustyniak; Irena Makulska; Maria Niemczuk; Adam Jankowski; Danuta Zwolińska
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2013-11-29       Impact factor: 4.291

10.  Vascular Endothelial Cell Injury Is an Important Factor in the Development of Encapsulating Peritoneal Sclerosis in Long-Term Peritoneal Dialysis Patients.

Authors:  Mitsuhiro Tawada; Yasuhiko Ito; Chieko Hamada; Kazuho Honda; Masashi Mizuno; Yasuhiro Suzuki; Fumiko Sakata; Takeshi Terabayashi; Yoshihisa Matsukawa; Shoichi Maruyama; Enyu Imai; Seiichi Matsuo; Yoshifumi Takei
Journal:  PLoS One       Date:  2016-04-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.